SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-07-027673
Filing Date
2007-04-11
Accepted
2007-04-11 14:17:34
Documents
2
Effectiveness Date
2007-04-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A a07-10425_1defa14a.htm DEFA14A 29862
2 GRAPHIC g104251dei001.gif GRAPHIC 2894
  Complete submission text file 0001104659-07-027673.txt   35483
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 07760963
SIC: 2834 Pharmaceutical Preparations